Chardan

Chardan’s David Lederman and Omar Khalil are heading to London for the Life Sciences Week, Nov. 15-20. The week will bring together leaders across biotech, biopharma, medtech, healthcare services & more. We look forward to connecting!

Chardan’s Linkesh Swaminathan and Yingjie Weng are heading to Malaysia for the Route to U.S. Capital Markets Summit on Nov. 6. The summit will explore how ASEAN businesses can navigate the path to the U.S. public markets. We look forward to connecting!

Best Performing Coins: • @AethirEco (ATH): 4.8% • @Zcash (ZEC): 2.9% • @BNBCHAIN (BNB): 2.5% Worst Performing Coins: • DATA: -17.0% • BERA: -15.0% • INJ: -11.1% More info: [email protected]

Chardan’s Andreas Argyrides initiated coverage on MNKD (Buy, $10). MannKind Corporation is a commercial-stage biopharmaceutical company focused on inhaled and device-enabled therapies for cardiometabolic and orphan lung diseases. More info: [email protected]

Thank you to everyone who joined us for Chardan’s 10th Annual Healthcare Conference! We’re grateful to our presenting companies, investors, speakers, KOLs & attendees for making this year’s event a success. See you next year!

Chardan’s Gautam Chukka initiated coverage on TVRD (Buy, $8). Tvardi Therapeutics is developing oral, small-molecule STAT3 inhibitors for inflammatory and proliferative diseases. More info: [email protected]

Best Performing Coins: • @injective (INJ): 25.6% • @NEARProtocol (NEAR): 3.4% • @worldcoinfnd (WLD): 1.5% Worst Performing Coins: • CC: -15.6% • BERA: -13.6% • RAIN: -13.5% More info: [email protected]

Panel preview for our 10th Annual Healthcare Conference, Oct. 20 in NYC: Right Target, Small Effect? Rethinking CNS, examining target engagement and clinical outcomes across CNS programs. For informational purposes only. Not investment advice. chardan.com/legal-disclosure…

Chardan is pleased to act as the Exclusive Sales Agent on Corvex Inc.’s (NASDAQ: MOVE) $250M ATM. Corvex provides AI cloud infrastructure for workloads including GPU-accelerated computing, confidential computing and inference services. More info: [email protected]

Panel preview for our 10th Annual Healthcare Conference, Oct. 20 in NYC: The Next Frontiers in MPN Treatment, discussing data across MF, ET and PV and questions beyond JAK inhibition. For informational purposes only. Not investment advice. chardan.com/legal-disclosure…

Panel preview for our 10th Annual Healthcare Conference, Oct. 20 in NYC: Cracking the Cold Tumor in MSS Colon Cancer, reviewing emerging evidence and open questions in immunotherapy. For informational purposes only. Not investment advice. chardan.com/legal-disclosure…

Panel preview for our 10th Annual Healthcare Conference, Oct. 20 in NYC: The Crowded Second Act in Neuromuscular Autoimmunity, discussing treatment across MG, CIDP and MMN. For informational purposes only. Not investment advice. chardan.com/legal-disclosure…

Panel preview for our 10th Annual Healthcare Conference, Oct. 20 in NYC: The Next Frontier in Ophthalmic Gene Therapy for IRDs, examining delivery, retinal coverage and open questions. For informational purposes only. Not investment advice. chardan.com/legal-disclosure…

Panel preview for our 10th Annual Healthcare Conference, Oct. 20 in NYC: Beyond Knockdown: Building the RNA Toolkit, exploring approaches to editing, restoring and controlling gene expression. For informational purposes only. Not investment advice. chardan.com/legal-disclosure…

Panel preview for our 10th Annual Healthcare Conference, Oct. 20 in NYC: The Next Era of Disease Modification in PAH & PH-ILD, examining vascular remodeling and earlier intervention. For informational purposes only. Not investment advice. chardan.com/legal-disclosure…

Chardan’s Gautam Chukka initiated coverage on FDMT (Buy, $25). 4D Molecular Therapeutics develops next-generation gene therapies using its proprietary Therapeutic Vector Evolution platform. More info: [email protected]

Best Performing Coins: • 0G: 16.4% • SKY: 13.4% • WLD: 12.8% Worst Performing Coins: • ZEC: -16.1% • ENA: -13.3% • RAIN: -9.8% More info: [email protected]

Best Performing Coins: • @NEARProtocol (NEAR): 58.9% • @Zcash (ZEC): 33.9% • @ethena (ENA): 20.4% Worst Performing Coins: • RAIN: -13.4% • DATA: 0.6% • TRX: -0.1% More info: [email protected]

Chardan’s Gautam Chukka initiated coverage on PVLA (Buy, $240). @PalvellaTX is a clinical-stage company focused on developing therapies for rare genetic skin diseases. More info: [email protected]

Join us October 20, 2026 in New York City for Chardan's 10th Annual Healthcare Conference, featuring leading biotech innovators and thought leaders discussing the next wave of transformative healthcare advancements. More info: [email protected]